This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Javier Chaparro-Riggers, Ph.D.
Vice President, BioMedicine Design at Pfizer
Speaker

Profile

Javier joined Pfizer in 2007 and is leading the BioTherapeutic Discovery department within Biomedicine Design. He is responsible for leading biotherapeutic discovery work, including lead generation and optimization, biophysical characterization, and non-GLP biotherapeutic production. During his tenure at Pfizer he worked on conventional/bispecific/trispecific antibodies, antibody-cytokine fusions, antibody drug conjugates, CAR T cells, oncolytic viruses and mRNA therapies. Javier is interested in understanding the underlying biology of drug design and delivery and engineering solutions for challenges associated with developing the next generation of biotherapeutics.

Agenda Sessions

  • Co-Chairs' Remarks: Engineering Considerations for Candidate Selection and Developability

    1:00pm
  • Optimizing Antibodies for Efficacy

    1:15pm